Order Article Reprints

Campos LB, de Almeida NAA, de Santana CG, Barbosa ENP, Horta MAP, Amendola Pires M, Brandão Mello CE, de Paula VS, de Barros JJF. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV. Viruses. 2023; 15(1):187. https://doi.org/10.3390/v15010187

Campos, Letícia Bomfim, Nathália Alves Araújo de Almeida, Catarina Góis de Santana, Evorah Nascimento Pereira Barbosa, Marco Aurelio Pereira Horta, Márcia Amendola Pires, Carlos Eduardo Brandão Mello, Vanessa Salete de Paula, and José Júnior França de Barros. 2023. "Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV" Viruses 15, no. 1: 187. https://doi.org/10.3390/v15010187

Campos, L. B., de Almeida, N. A. A., de Santana, C. G., Barbosa, E. N. P., Horta, M. A. P., Amendola Pires, M., Brandão Mello, C. E., de Paula, V. S., & de Barros, J. J. F. (2023). Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV. Viruses, 15(1), 187. https://doi.org/10.3390/v15010187